Josep Puig
University of Manitoba
22 Papers
37 Citations
Josep Puig is an academic researcher from University of Manitoba. The author has contributed to research in topics: Medicine & Cerebral blood flow. The author has an hindex of 9, co-authored 22 publications. Previous affiliations of Josep Puig include University of Girona.
Chat about Author
Papers
From "Time is Brain" to "Imaging is Brain": A Paradigm Shift in the Management of Acute Ischemic Stroke.
Josep Puig,Jai Jai Shiva Shankar,David S Liebeskind,Mikel Terceño,Kambiz Nael,Andrew M. Demchuk,Bijoy K Menon,Dar Dowlatshahi,Carlos Leiva-Salinas,Max Wintermark,Götz Thomalla,Yolanda Silva,Joaquín Serena,Salvador Pedraza,Marco Essig +14 more
TL;DR: The approach to reperfusion therapies continues to evolve, and imaging is acquiring a greater role in the diagnostic work‐up and treatment decisions as shown in recent clinical trials with extended time window.
77
Pseudoprogression as an adverse event of glioblastoma therapy
Carmen Balana,Jaume Capellades,Estela Pineda,Anna Estival,Josep Puig,Sira Domenech,Eugenia Verger,Teresa Pujol,Maria Martinez-Garcia,Laura Oleaga,JoseMaria Velarde,Carlos Mesia,Rafael Fuentes,J. Marruecos,Sonia Del Barco,Salvador Villà,Cristina Carrato,Oscar Gallego,Miguel Gil-Gil,Jordi Craven-Bartle,Francesc Alameda +20 more
TL;DR: PsP confounds the evaluation of disease and does not confer a survival advantage in glioblastoma, and only MGMT methylation status was associated to PsP.
Whole-Brain Dynamics in Aging: Disruptions in Functional Connectivity and the Role of the Rich Club.
Anira Escrichs,Carles Biarnes,Josep Garre-Olmo,José Manuel Fernández-Real,Rafel Ramos,Reinald Pamplona,Ramon Brugada,Joaquín Serena,Lluís Ramió-Torrentà,Gabriel Coll-de-Tuero,Lluis Gallart,Jordi Barretina,Joan C. Vilanova,Jordi Mayneris-Perxachs,Marco Essig,Chase R. Figley,Salvador Pedraza,Josep Puig,Gustavo Deco +18 more
TL;DR: In this paper, the authors employed two data-driven whole-brain approaches based on the phase synchronization of blood-oxygen-level-dependent signals to analyze resting-state fMRI data from 620 subjects divided into two groups (middle-age group (n = 310); age range, 50-64 years versus older group(n = 210); age ranges, 65-91 years).
43
Imaging-based Selection for Endovascular Treatment in Stroke.
TL;DR: Challenges in the subgroups of patients who were excluded from recent EVT trials and with limited evidence to prove the efficacy of EVT are focused on, such as patients with low NIHSS score, distal occlusion, or large ischemic core.
28
The Aging Imageomics Study: rationale, design and baseline characteristics of the study population.
Josep Puig,Carles Biarnes,Salvador Pedraza,Joan C. Vilanova,Reinald Pamplona,José Manuel Fernández-Real,Ramon Brugada,Rafel Ramos,Gabriel Coll-de-Tuero,Laia Calvo-Perxas,Joaquín Serena,Lluís Ramió-Torrentà,Jordi Gich,Lluis Gallart,M. Portero-Otin,Angel Alberich-Bayarri,Ana Jimenez-Pastor,Eduardo Camacho-Ramos,Jordi Mayneris-Perxachs,Victor Pineda,Raquel Font,Anna Prats-Puig,Mariano-Luis Gacto,Gustavo Deco,Anira Escrichs,Bonaventura Clotet,Roger Paredes,Eugenia Negredo,Bruno Triaire,Manuel Rodríguez,Alberto Heredia-Escámez,R. Coronado,Wolter de Graaf,Valentin Prevost,Anca Mitulescu,Pepus Daunis-i-Estadella,Santiago Thió-Henestrosa,Felip Miralles,Vicent Ribas-Ripoll,Manel Puig-Domingo,Marco Essig,Chase R. Figley,Teresa D. Figley,Benedict C. Albensi,Ahmed Bilal Ashraf,Johan H. C. Reiber,Giovanni Schifitto,Uddin Md Nasir,Carlos Leiva-Salinas,Max Wintermark,Kambiz Nael,Joan Vilalta-Franch,Jordi Barretina,Josep Garre-Olmo +53 more
TL;DR: The Aging Imageomics Study aims to identify biomarkers of human aging by analyzing imaging, biopsychosocial, cardiovascular, metabolomic, lipidomic, and microbiomic variables, and to cultivate a deeper understanding about various biological factors that underlie healthy and unhealthy aging.
22